케이바이오랩스

Filings by 케이바이오랩스 span 2 companies, the busiest being 인콘 and 케이바이오랩스. Over a trading history stretching from 9 July 2021 to 4 September 2026, the count stands at 28 filings.

No open-market purchase appears, only 26 sales. The totals exclude 26 filings filed without an amount. In 2026 alone, the filings show no purchases and 3 sales.

The newest entry dates from 4 September 2026: an open-market sale, in 인콘. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.